The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Abiomed Inc

Nasdaq: ABMD
Last

(U.S.) $110.17

Today's change+0.88 +0.81%
Updated July 1 4:00 PM EDT. Delayed by at least 15 minutes.
 

Abiomed Inc

Nasdaq: ABMD
Last

(U.S.) $110.17

Today's change+0.88 +0.81%
Updated July 1 4:00 PM EDT. Delayed by at least 15 minutes.

Abiomed Inc Hits New 100-day High

Abiomed Inc closed up Friday by (U.S.)$0.88 or 0.81% to (U.S.)$110.17 and setting a new 100-day high. Over the last five days, shares have gained 9.76% and 22.03% year to date. Shares have outperformed the S&P 500 by 65.29% during the last year.

Key company metrics

  • Open(U.S.) $109.71
  • Previous close(U.S.) $109.29
  • High(U.S.) $110.20
  • Low(U.S.) $108.89
  • Bid / Ask(U.S.) $100.10 / (U.S.) $0.00
  • YTD % change+22.03%
  • Volume355,337
  • Average volume (10-day)1,008,354
  • Average volume (1-month)620,925
  • Average volume (3-month)637,434
  • 52-week range(U.S.) $64.03 to (U.S.) $110.68
  • Beta1.09
  • Trailing P/E129.61×
  • P/E 1 year forward98.17×
  • Forward PEG3.57×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $0.85
Updated July 1 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.20%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue94867673
Total other revenue--------
Total revenue94867673
Gross profit79736463
Total cost of revenue15131211
Total operating expense74686458
Selling / general / administrative45424037
Research & development14141210
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income20171315
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax20171315
Income after tax111189
Income tax, total9756
Net income111189
Total adjustments to net income--------
Net income before extra. items111189
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items111189
Inc. avail. to common incl. extra. items111189
Diluted net income111189
Dilution adjustment--------
Diluted weighted average shares45454544
Diluted EPS excluding extraordinary itemsvalue per share0.240.230.170.20
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.240.230.170.20